Upgrade to SI Premium - Free Trial

H.C. Wainwright Reiterates Buy Rating on AnaptysBio (ANAB)

September 22, 2026 7:36 AM
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating and $95.00 price target on AnaptysBio (NASDAQ: ANAB).The analyst commented: "Yesterday ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments